GlassScriptPhysician profile
Ashley E Mychak
NPI 1861831075
$83,582.42
in general payments reported to CMS, 2019-2025
24 companies · $50K in 2025
The $50K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,251 · 2020: $145 · 2021: $110 · 2022: $850 · 2023: $5,932 · 2024: $24K · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $60K · Travel and Lodging: $13K · Food and Beverage: $7,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $59,650.00 |
| Travel and Lodging | $13,215.14 |
| Food and Beverage | $7,361.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $33,768.55 | 2022-2025 | |
| Bone Support INC. | $32,567.06 | 2023-2025 | Ceramentbone Void Filler, Cerament G |
| Polynovo North America LLC | $4,168.85 | 2024-2025 | Novosorb Btm |
| Stryker Corporation | $3,036.32 | 2019-2024 | Inbone, Salvation, Infinity |
| Integra Lifesciences Corporation | $2,374.86 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medline Industries LP | $2,152.46 | 2019-2025 | |
| Orthofix Medical, INC. | $1,919.60 | 2025 | Truelok, Ankle Compression Nailing System |
| Arteriocyte Medical Systems, INC. | $1,273.52 | 2019 | |
| Bioventus LLC | $359.52 | 2022-2023 | Stimrouter Implantable Kit |
| Organogenesis INC. | $339.48 | 2023-2024 | Puraply Wound Matrix, Puraply |
| Ets Wound Care LLC | $253.76 | 2023-2024 | Mirragen Advanced Wound Matrix |
| Zimmer Biomet Holdings, INC. | $237.95 | 2020-2023 | |
| Lifenet Health | $228.38 | 2025 | Theragenesis Wound Matrix |
| Checkpoint Surgical, INC | $201.46 | 2022 | |
| Kerecis Limited | $118.82 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $115.12 | 2019 | |
| Paratek Pharmaceuticals, INC. | $113.94 | 2025 | Nuzyra |
| Smith+Nephew, INC. | $83.38 | 2019-2020 | |
| Kci USA, INC. | $68.69 | 2022 | |
| Boston Scientific Corporation | $63.00 | 2023 | |
| Paragon 28, INC. | $56.33 | 2023 | Additive Orthopedics |
| Terumo Bct, INC. | $38.76 | 2019 | |
| Davol INC. | $25.06 | 2023 | |
| Polarityte, INC. | $17.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Mychak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.